Effect of serum uric acid on prognosis of drug-eluting stent implantation for patients with coronary bifurcated lesions
Abstract Purpose To investigate the effect of hyperuricemia on prognosis of drug-eluting stent implantation for patients with coronary bifurcated lesions. Materials and methods Patients with coronary bifurcation lesions treated with drug-eluting stent implantation were retrospectively enrolled. The clinical, interventional and follow-up data were analyzed. Results Totally, 193 patients were enrolled, including 59 with hyperuricemia and 134 without hyperuricemia. Serum triglyceride (1.73 vs. 1.44 mmol/L) and creatinine (70.0 vs. 61.0µmol/L) levels were significantly (P < 0.05) higher in the hyperuricemia than in the non-hyperuricemia group. During follow-up, seven patients died, including one (14.3%) death in the hyperuricemia and six (85.7%) in the non-hyperuricemia group. Twelve patients experienced revascularization, including 5 (41.7%) in the hyperuricemia group and 7 (58.3%) in the non-hyperuricemia group. Seventy patients were readmitted to the hospital because of cardiac reasons, including 36 (51.4%) patients in the hyperuricemia and 34 (48.6%) in the non-hyperuricemia group. The risk of cardiac readmission was significantly (P < 0.001) greater in the non-hyperuricemia than in the hyperuricemia group (30.10 vs. 24.33 m). Age was a significant (P = 0.01) independent risk factor for all-cause mortality after cardiac intervention with a hazard ratio (HR) of 1.12 (95% CI 1.03–1.23). Diabetes mellitus was the only significant (P = 0.007) independent risk factor for revascularization, with a HR of 5.13 (95% CI 1.56–16.91). Male sex (P = 0.023, HR 2.21 with 95% CI of 1.12–4.38), total cholesterol (P = 0.004, HR 2.53 with 95% CI 1.35–4.74), and hyperuricemia (P = 0.001, HR 2.37 with 95% CI 1.44–3.89) were significant independent risk factors for cardiac readmission. Conclusion Hyperuricemia is an independent risk factor for cardiogenic readmission rather than for all-cause mortality and revascularization after drug-eluting stent implantation for patients with coronary bifurcation lesions..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
ResearchSquare.com - (2024) vom: 07. März Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gao, Hongjie [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
doi: |
10.21203/rs.3.rs-3983821/v1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XRA042836638 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | XRA042836638 | ||
003 | DE-627 | ||
005 | 20240308131537.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240308s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21203/rs.3.rs-3983821/v1 |2 doi | |
035 | |a (DE-627)XRA042836638 | ||
035 | |a (ResearchSquare)10.21203/rs.3.rs-3983821/v1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gao, Hongjie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of serum uric acid on prognosis of drug-eluting stent implantation for patients with coronary bifurcated lesions |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Purpose To investigate the effect of hyperuricemia on prognosis of drug-eluting stent implantation for patients with coronary bifurcated lesions. Materials and methods Patients with coronary bifurcation lesions treated with drug-eluting stent implantation were retrospectively enrolled. The clinical, interventional and follow-up data were analyzed. Results Totally, 193 patients were enrolled, including 59 with hyperuricemia and 134 without hyperuricemia. Serum triglyceride (1.73 vs. 1.44 mmol/L) and creatinine (70.0 vs. 61.0µmol/L) levels were significantly (P < 0.05) higher in the hyperuricemia than in the non-hyperuricemia group. During follow-up, seven patients died, including one (14.3%) death in the hyperuricemia and six (85.7%) in the non-hyperuricemia group. Twelve patients experienced revascularization, including 5 (41.7%) in the hyperuricemia group and 7 (58.3%) in the non-hyperuricemia group. Seventy patients were readmitted to the hospital because of cardiac reasons, including 36 (51.4%) patients in the hyperuricemia and 34 (48.6%) in the non-hyperuricemia group. The risk of cardiac readmission was significantly (P < 0.001) greater in the non-hyperuricemia than in the hyperuricemia group (30.10 vs. 24.33 m). Age was a significant (P = 0.01) independent risk factor for all-cause mortality after cardiac intervention with a hazard ratio (HR) of 1.12 (95% CI 1.03–1.23). Diabetes mellitus was the only significant (P = 0.007) independent risk factor for revascularization, with a HR of 5.13 (95% CI 1.56–16.91). Male sex (P = 0.023, HR 2.21 with 95% CI of 1.12–4.38), total cholesterol (P = 0.004, HR 2.53 with 95% CI 1.35–4.74), and hyperuricemia (P = 0.001, HR 2.37 with 95% CI 1.44–3.89) were significant independent risk factors for cardiac readmission. Conclusion Hyperuricemia is an independent risk factor for cardiogenic readmission rather than for all-cause mortality and revascularization after drug-eluting stent implantation for patients with coronary bifurcation lesions. | ||
650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
700 | 1 | |a Liu, Dongchao |4 aut | |
700 | 1 | |a Xue, Zheng |4 aut | |
700 | 1 | |a Qi, Jingxian |4 aut | |
700 | 1 | |a Yin, Liang |4 aut | |
700 | 1 | |a Duan, Bing |4 aut | |
700 | 1 | |a Wu, Lin |4 aut | |
700 | 1 | |a Yang, Kun |4 aut | |
700 | 1 | |a Gao, Bulang |4 aut | |
700 | 1 | |a Cao, Qinying |4 aut | |
700 | 1 | |a Mi, Jie |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2024) vom: 07. März |
773 | 1 | 8 | |g year:2024 |g day:07 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-3983821/v1 |z kostenfrei |3 Volltext |
912 | |a GBV_XRA | ||
951 | |a AR | ||
952 | |j 2024 |b 07 |c 03 |